CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 42 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $16,000 | -38.5% | 2,782 | -37.9% | 0.02% | -28.6% |
| Q1 2017 | $26,000 | +36.8% | 4,482 | +21.7% | 0.02% | +162.5% |
| Q4 2016 | $19,000 | -5.0% | 3,682 | -62.9% | 0.01% | -38.5% |
| Q3 2016 | $20,000 | +122.2% | 9,914 | +119.9% | 0.01% | +85.7% |
| Q2 2016 | $9,000 | +350.0% | 4,509 | +457.4% | 0.01% | +600.0% |
| Q1 2016 | $2,000 | – | 809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|